Search for Clinical Trial Results

Sponsored By

Hyperparathyroidism, Secondary - 21 Studies Found

Status Study
Completed Study Name: Safety, Tolerability and Pharmacokinetics of KAI-4169 in Hemodialysis Subjects With Secondary Hyperparathyroidism
Condition: Hyperparathyroidism, Secondary
Date: 2010-05-28
Interventions:
  • Drug: Saline Single IV injecti
Completed Study Name: Extension Study of Etelcalcetide in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease (CKD) on Hemodialysis
Condition: Hyperparathyroidism, Secondary
Date: 2013-02-05
Interventions: Drug: Etelcalcetide Administered by bolus injection into the venous line of the dialysis circuit at the
Completed Study Name: Efficacy and Safety of Etelcalcetide (AMG 416) in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease on Hemodialysis
Condition: Hyperparathyroidism, Secondary
Date: 2013-02-05
Interventions:
  • Drug: Etelcalcetide Administer
Completed Study Name: Efficacy and Safety of Etelcalcetide (AMG 416) in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease (CKD) on Hemodialysis
Condition: Hyperparathyroidism, Secondary
Date: 2013-02-07
Interventions:
  • Drug: Etelcalcetide Administer
Completed Study Name: Compare the Efficacy of Cinacalcet vs Traditional Vitamin D for Secondary Hyperparathyroidism (SHPT) Among Subjects Undergoing Hemodialysis
Condition: Hyperparathyroidism, Secondary
Date: 2010-08-12
Interventions:
  • Drug: Traditional Vitamin D Therapy

Active, not recruiting Study Name: To Assess the Long-term Safety of AMG 416 in the Treatment of SHPT in Subjects With CKD on Hemodialysis
Condition: Hyperparathyroidism, Secondary
Date: 2014-03-03
Interventions: Drug: AMG 416 Subjects will be administered IV AMG 416 at the end of their regular dialysis sessions on
Completed Study Name: Safety, Tolerability and Efficacy of Etelcalcetide in Hemodialysis Patients With Secondary Hyperparathyroidism
Condition: Secondary Hyperparathyroidism
Date: 2010-12-03
Interventions:
  • Drug: Etelcalcetide Administer
Completed Study Name: Maintenance Vitamin D Therapy for Secondary Hyperparathyroidism (2HPT)
Condition: Secondary Hyperparathyroidism
Date: 2009-01-22
Interventions:
  • Drug: 1.0 μg/day Alfacalcidol

Completed Study Name: Cinacalcet in Management of Secondary Hyperparathyroidism in Haemodialysis Patients
Condition: Secondary Hyperparathyroidism
Date: 2015-01-11
Interventions: Drug: Combination Cinacalcet with Vitamin D analogue Depending on the iPTH level and the serum calcium l
Completed Study Name: LEO 27847 - Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study in Secondary Hyperparathyroidism Patients
Condition: Secondary Hyperparathyroidism
Date: 2010-07-02
Interventions: Drug: LEO 27847 First in patient
Next >>>